logo
logo
Sign in

Respiratory Inhalers Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Respiratory Diseases

avatar
Vedant B
Respiratory Inhalers Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Respiratory Diseases

Respiratory inhalers, also known as inhalers, are medical devices used for administering medicine to the lungs to provide relief and improve symptoms for patients suffering from respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The key advantages of inhalers are that they provide a faster action compared to oral drugs and allow for localized drug delivery directly into the airways, thus improving medication adherence and treatment outcomes. With rising air pollution levels and changing lifestyle patterns, the prevalence of respiratory diseases has increased significantly across both developed and developing countries. This growing patient pool is one of the key drivers augmenting growth of the global respiratory inhaler market.

The Global respiratory inhalers market is estimated to be valued at US$ 34.05 Mn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Respiratory Inhalers Market are Simpson Strong-Tie Co., Inc., Fast-Stairs Inc., Pylex Products, Dolle USA, Universal Forest Products, Inc., Regal Ideas Inc., Arke Stairs, The Iron Shop, EZ Stairs & Century Aluminum Railings. These players are focusing on new product launches and expansion strategies to strengthen their market presence. For instance, in 2022, Simpson Strong-Tie launched new concealed hanger, fastener, and connector products.

The key opportunities in the respiratory inhalers market include increasing penetration in emerging economies and growing adoption of digital health solutions. Emerging countries in Asia Pacific and Latin America present lucrative prospects for players given rising awareness and improving access to healthcare infrastructures. Integration of respiratory inhalers with connected sensors and apps allow for remote monitoring of usage patterns and treatment adherence, thereby improving patient outcomes.

Globally, players are focusing on collaborations, acquisitions and geographic expansion strategies to increase their footprint. For example, in 2023, Simpson Strong-Tie partnered with a Chinese firm to expand bundled connector offerings in Asia. Similarly, Fast-Stairs launched operations in Mexico through a subsidiary to tap growth opportunities in Latin American countries.

Market drivers

The increasing prevalence of respiratory diseases owing to rising pollution levels and changing lifestyle is a key growth driver for the respiratory inhalers market. As per WHO, over 300 million people suffer from asthma and over 65 million have COPD globally. Additionally, with aging population susceptible to respiratory issues, the demand for effective treatment like inhalers is anticipated to witness steady rise over the coming years.

Market restraints

Preference for generic drugs and cheaper alternatives in price sensitive markets may hamper the growth of established brands in the respiratory inhalers segment. Further, lack of disease awareness and accessibility challenges in underdeveloped regions continue to restrict market potential to a certain extent. High price of novel drug delivery inhalers also act as a restraint for widespread adoption.


Segment Analysis

Dry powder inhalers segment currently dominates the respiratory inhalers market. Dry powder inhalers offer benefits such as less difficulty in coordinating activation and inhalation and possibility of inclusion of larger amounts of medication as compared to metered dose inhalers. However, the demand for soft mist inhalers is expected to grow significantly during the forecast period owing to their advantages such as ease of use, better toxicity profile and high stability of the formulated drug.

Global Analysis

North America region is expected to continue its dominance in the respiratory inhalers market during the forecast period. High patient awareness about inhalation therapy and availability of advanced inhalers drive the North America respiratory inhalers market. However, Asia Pacific region is likely to witness the highest growth rate owing to rising incidences of respiratory diseases such as asthma and COPD, increasing healthcare expenditures, and growing demand for quality medical devices in emerging countries such as China and India in this region. Europe region currently captures a significant market share and is anticipated to maintain a steady growth due to rising prevalence of respiratory diseases and improving reimbursement scenario in the region.


Get more insights on Respiratory Inhalers Market

collect
0
avatar
Vedant B
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more